In The News
ENDPOINTS
06.2.2023
Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships; Alkermes locks in CEO for oncology spinout
News
ENDPOINTS
04.19.2023
KRAS, one of cancer’s toughest targets, sees a surge of new therapies trying to limit side effects: #AACR23
News
ENDPOINTS
11.28.2022
Endpoints’ 10 biggest stories of 2022
News
ENDPOINTS
09.22.2022
The Endpoints 11: The top private biotechs in pursuit of new drugs. Pushing the envelope with powerful new technologies
News
Business Insider
07.28.2022
Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs
News
ENDPOINTS
07.26.2022
‘Go quickly’: Amgen R&D vet Dirk Nagorsen jumps to a startup with big plans for TCRs
News
ENDPOINTS
06.15.2022
No introductions necessary: A TCR upstart with deep-pocket backers partners with one of the new players in the hot gene editing field
News
GeekWire
03.22.2022
Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to treat solid tumors
News
ENDPOINTS
03.22.2022
A new cell therapy startup from an immunotherapy pioneer raises $175M in KRAS quest
News
Fierce Biotech
03.22.2022
Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field
News
Boston Globe
03.22.2022
Affini-T Therapeutics launches with $175 million for cancer treatments
News
Boston Business Journal
03.22.2022
Vida, Bayer throw weight behind $175M T-cell startup
News
Business Insider
03.22.2022
See the 24-slide pitch deck a new biotech startup just used to raise $175 million to develop the next cancer breakthrough
News
BioSpace
01.14.2022
New Cell Therapy Player Makes Public Debut at JPM
News
GeekWire
01.13.2022
Juno co-founder launches ambitious new startup with Fred Hutch colleagues to treat cancer
News
STAT
01.13.2022
A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies
News